BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34544292)

  • 1. Merging care and prevention: preventive properties of antiretroviral drugs and HIV chronification in the case of Switzerland.
    Genre N; Panese F
    Anthropol Med; 2022 Mar; 29(1):14-28. PubMed ID: 34544292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral agents in pre-exposure prophylaxis: emerging and advanced trends in HIV prevention.
    Yap PK; Loo Xin GL; Tan YY; Chellian J; Gupta G; Liew YK; Collet T; Dua K; Chellappan DK
    J Pharm Pharmacol; 2019 Sep; 71(9):1339-1352. PubMed ID: 31144296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical use of antiretroviral resources for HIV prevention in resource poor settings.
    Rennie S
    Dev World Bioeth; 2013 Aug; 13(2):79-86. PubMed ID: 23724978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [PrEP in French-speaking Switzerland: between anxiety and trust, antiretroviral use for HIV prevention].
    Genre N; Christinet V
    Rev Med Suisse; 2023 Sep; 19(842):1714-1717. PubMed ID: 37728266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance.
    Afassinou K; Chirove F; Govinder KS
    Math Biosci; 2017 Mar; 285():92-101. PubMed ID: 28095307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Representations of Pre-exposure Prophylaxis, Informal Antiretroviral Medication Use for HIV Prevention, and Diversion on Geosocial Networking Apps among Men Who Have Sex with Men.
    Buttram ME; Kurtz SP
    AIDS Behav; 2019 Jul; 23(7):1790-1796. PubMed ID: 30255385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with antiretroviral-susceptible HIV in an individual adherent to pre-exposure prophylaxis: strategies for treatment initiation.
    Hughes JM; Tan DH; Anderson P; Bodhinayake J; MacPherson PA
    Int J STD AIDS; 2021 May; 32(6):578-581. PubMed ID: 33663292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretrovirals for HIV prevention: when should they be recommended?
    Kiselinova M; De Spiegelaere W; Verhofstede C; Callens SF; Vandekerckhove L
    Expert Rev Anti Infect Ther; 2014 Apr; 12(4):431-45. PubMed ID: 24621251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
    Idoko J; Folayan MO
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.
    Hankins CA; Dybul MR
    Curr Opin HIV AIDS; 2013 Jan; 8(1):50-8. PubMed ID: 23201856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARV-based HIV prevention for women - where we are in 2014.
    Mastro TD; Sista N; Abdool-Karim Q
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19154. PubMed ID: 25224614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiretroviral drugs-based HIV prevention methods: what impact on the HIV epidemic?].
    Supervie V
    Med Sci (Paris); 2013 Apr; 29(4):373-82. PubMed ID: 23621932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV prevention: better choice for better coverage.
    Bekker LG; Pike C; Hillier SL
    J Int AIDS Soc; 2022 Jan; 25(1):e25872. PubMed ID: 35030296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethics of ARV based prevention: treatment-as-prevention and PrEP.
    Haire B; Kaldor JM
    Dev World Bioeth; 2013 Aug; 13(2):63-9. PubMed ID: 23594312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming.
    Hillis A; Germain J; Hope V; McVeigh J; Van Hout MC
    AIDS Behav; 2020 Nov; 24(11):3056-3070. PubMed ID: 32274670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.
    Guise A; Albers ER; Strathdee SA
    Addiction; 2017 Apr; 112(4):572-578. PubMed ID: 27273843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrEP as Peri-conception HIV Prevention for Women and Men.
    Heffron R; Pintye J; Matthews LT; Weber S; Mugo N
    Curr HIV/AIDS Rep; 2016 Jun; 13(3):131-9. PubMed ID: 26993627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of PrEP on HIV Incidence Among Men Who Have Sex With Men in the Context of Condom Use, Treatment as Prevention, and Seroadaptive Practices.
    LeVasseur MT; Goldstein ND; Tabb LP; Olivieri-Mui BL; Welles SL
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):31-40. PubMed ID: 28961679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "In reality, it is complex and difficult": UK nurses' perspectives on "treatment as prevention" within HIV care.
    Evans C; Bennett J; Croston M; Brito-Ault N; Bruton J
    AIDS Care; 2015; 27(6):753-7. PubMed ID: 25650545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.